Abstract

The RS-isomers of β-mercapto-α-ketoglutarate, β-methylmercapto-α-ketoglutarate and β-methylmercapto-α-hydroxyglutarate have been synthesized. β-Mercapto-α-ketoglutarate was a potent inhibitor, competitive with isocitrate and noncompetitive with NADP +, of the mitochondrial NADP-specific isozyme from pig heart ( K i = 5 nM; K m( DL-isocitrate) K i(RS-β- mercapto-α-ketoglutarate) = 650) and pig liver, the cytosolic isozyme from pig liver (I 0·5 = 23 n m), and the NADP-linked enzymes from yeast ( K i = 58 nM) and Escherichia coli ( K i = 58 nM) at pH 7.4 and with Mg 2+ as activator. β-Mercapto-α-ketoglutarate was also an effective inhibitor of NADP-isocitrate-dehydrogenase activity in intact liver mitochondria. β-Mercapto-α-ketoglutarate was a much less potent inhibitor for heart NAD-isocitrate dehydrogenase ( K i = 520 nM) than for the NADP-specific enzyme. β-Methylmercapto-α-ketoglutarate (I 0·5 = 10 μ m) was a much less effective inhibitor than the β-mercapto derivative for heart NADP-isocitrate dehydrogenase. The β-sulfur substituted α-ketoglutarates were substrates for the oxidation of NADPH by heart NADP-isocitrate dehydrogenase without requiring CO 2. β-Methylmercapto-α-hydroxyglutarate, the expected product of reduction of β-methylmercapto-α-ketoglutarate, did not cause reduction of NADP + but it was an inhibitor competitive with isocitrate for NADP-isocitrate dehydrogenase. The β-sulfur substituted α-ketoglutarate derivatives were alternate substrates for α-ketoglutarate dehydrogenase and the cytosolic and mitochondrial isozymes of heart aspartate aminotransferase but had no effect on glutamate dehydrogenase or alanine aminotransferase.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call